Expertise in
7
conditions

Ilse Hoffman

Leuven, VLG, BE 
Expertise in
7
conditions
Leuven, VLG, BE 

Overview

Ilse Hoffman practices practicing medicine in Leuven, Belgium.

Ms. Hoffman is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Small Bowel Resection.

She is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Leuven, VLG, Belgium
Other Locations
Brussels, BRU, Belgium
Antwerpen, VLG, Belgium
Wilrijk, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 1 Less Clinical Trial

73 Total Publications

Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel disease.
Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: December 22, 2025

Frequently Asked Questions about Ilse Hoffman

Is Ilse Hoffman a top-rated expert for Crohn's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Ilse Hoffman is classified as an Distinguished expert for Crohn's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ilse Hoffman participate in research or clinical trials?

Yes. Ilse Hoffman has published 73 articles and abstracts on conditions like Crohn's Disease. You can view a list of Ilse Hoffman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hoffman's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile